News
Company news 
ViruSure launches first GMP-validated viral safety test based on Oxford Nanopore sequencing
Company news 
Singapore’s National Precision Medicine (NPM) programme engages Oxford Nanopore to advance understanding of the genetics of Singapore’s multi-ethnic p
Company news 
Oxford Nanopore Technologies and UMC Utrecht collaborate on 1,000 human genome sequencing project
Technology 
Oxford Nanopore opens genomics market with PromethION 2 Solo: the world’s first portable, high yield sequencer providing comprehensive DNA analysis for anyone, anywhere
Technology 
Oxford Nanopore launches PromethION 2 Integrated into open early access
Company news 
Oxford Nanopore at ASHG 2022: One sequencing platform for all your biology
Company news 
Oxford Nanopore and Genomics England announce new strategic research project to resolve undiagnosed rare disease cases
Interviews 
Interview: Using PromethION for Cancer, Collaborations and more
Interviews 
Interview: Sequencing the poplar with PromethION
Interviews 
Interview: The PromethION Experts at VIB
Interviews 
Interview: PromethION 24 and human disease research
Interviews 
Interview: Exploring complex disease in Asian populations with PromethION
Company news 
Innovations with ultra-long reads
Company news 
Blog: Resolving structural variants causing antithrombin deficiency
Company news 
Blog: cuteSV - a powerful tool to uncover the full spectrum of genomic structural variants
Company news 
Al Jalila Children’s Hospital advances rare disease identification through Oxford Nanopore sequencing, a new study shows | Oxford Nanopore Technologies